Search Results - "Biertz, F"

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort by Alter, Peter, Mayerhofer, Barbara A, Kahnert, Kathrin, Watz, Henrik, Waschki, Benjamin, Andreas, Stefan, Biertz, Frank, Bals, Robert, Vogelmeier, Claus F, Jörres, Rudolf A

“…A substantial prevalence of cardiovascular disease is known for COPD, but detection of its presence, relationship to functional findings and contribution to…”
Get full text

Long-term persistence of MRSA in re-admitted patients by Mattner, F, Biertz, F, Ziesing, S, Gastmeier, P, Chaberny, I. F

“…Background A better knowledge of methicillin-resistant Staphylococcus aureus (MRSA) persistence in hospitalised patients may impact on specific prevention…”
Get full text

Adverse effects of rabies pre-and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients by MATTNER, F, BITZ, F, GOEDECKE, M, VIERTEL, A, KUHN, S, GASTMEIER, P, MATTNER, L, BIERTZ, F, HEIM, A, HENKE-GENDO, C

“…The recent unfortunate rabies transmissions through solid organ transplants of an infected donor in Germany required the initiation of a vaccination program to…”
Get full text

Midregional proatrial naturetic peptide as predictors of all-cause mortality in recently diagnosed mild to moderate COPD--results from COSYCONET by Fähndrich, S, Herr, C, Teuteberg, S, Alter, P, Söhler, S, Soriano, D, Classen, J, Adams, J, Weinhold, V, Watz, H, Waschki, B, Zeller, T, Eichenlaub, M, Trudzinski, F. C, Michels, J. D, Omlor, A, Seiler, F, Moneke, I, Biertz, F, Stolz, D, Welte, T, Kauczor, H. U, Kahnert, K, Jörres, R. A, Vogelmeier, C. F, Bals, R, Andreas, Stefan, Alter, Peter, Bals, Robert, Behr, Jürgen, Kahnert, Kathrin, Bahmer, Thomas, Bewig, Burkhard, Ewert, Ralf, Stubbe, Beate, Ficker, Joachim H, Grohé, Christian, Held, Matthias, Henke, Markus, Herth, Felix, Kirsten, Anne-Marie, Watz, Henrik, Koczulla, Rembert, Kronsbein, Juliane, Kropf-Sanchen, Cornelia, Herzmann, Christian, Pfeifer, Michael, Randerath, Winfried J, Seeger, Werner, Studnicka, Michael, Taube, Christian, Timmermann, Hartmut, Schmeck, Bernd, Vogelmeier, Claus, Welte, Tobias, Wirtz, Hubert

“…Background MRproANP and COPAVP are prognostic markers for mortality in chronic obstructive pulmonary disease (COPD). Furthermore, these biomarkers predict…”
Get full text

D103 ALPHA 1-ANTITRYPSIN DEFICIENCY: 50 YEARS OF PROGRESS: Comorbidity Patterns In Alpha-1-Antitrypsin Deficiency Depend On Natural History And Substitution Therapy by Fahndrich, S W, Biertz, F, Karch, A, Kleibrink, B, Koch, A, Teschler, H, Welte, T, Greulich, T, Kauczor, H-U, Janciauskiene, S, Jorres, R, Vogelmeier, C, Bals, R

“…Rationale: Alpha-1-antitrypsin deficiency (AATD) is a rare inherited condition caused by mutations of the SERPINA1 gene and associated with liver and lung…”
Get full text

Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis by David, Sascha, Kümpers, Philipp, Seidler, Vega, Biertz, Frank, Haller, Hermann, Fliser, Danilo

“…Background. Natriuretic peptides such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) have become increasingly important in diagnosing left…”
Get full text

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET by Trudzinski, F. C., Jörres, R. A., Alter, P., Kahnert, K., Waschki, B., Herr, C., Kellerer, C., Omlor, A., Vogelmeier, C. F., Fähndrich, S., Watz, H., Welte, T., Jany, B., Söhler, S., Biertz, F., Herth, F., Kauczor, H.-U., Bals, R.

“…We studied whether in patients with stable COPD blood gases (BG), especially oxygenated hemoglobin (OxyHem) as a novel biomarker confer information on disease…”
Get full text

C80-B MULTI-MODALITY ASSESSMENT OF COPD, ASTHMA, AND ASTHMA-COPD OVERLAP SYNDROME: Transfer Factor For Carbon Monoxide In Patients With COPD And Diabetes: Results From The German Cosyconet Cohort by Kahnert, K, Lucke, T, Biertz, F, Lechner, A, Alter, P, Bals, R, Watz, H, Behr, J, Holle, R, Huber, R M, Karrasch, S, Stubbe, B, Wacker, M, Sohler, S, Wouters, E F M, Vogelmeier, C, Jorres, R

“…Methods Data from the initial visit of the German COPD cohort COSYCONET were used for analysis; data were obtained in 31 study centers. 2575 patients with…”
Get full text

A103 REVOLUTIONS IN OBSTRUCTIVE LUNG DISEASE IMAGING: Prediction Of Emphysema From Lung Function Parameters And Chest CT Scans Obtained In Clinical Routine: Results Of The German Cosyconet Study by Jorres, R A, Biertz, F, Vogel, C, Kauczor, H-U, Biederer, J, Jobst, B, Heinrich, J, Koch, A, Watz, H, Welte, T, Vogelmeier, C

Get full text

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort by Königsdorfer, Norbert, Jörres, Rudolf A, Söhler, Sandra, Welte, Tobias, Behr, Jürgen, Ficker, Joachim H, Bals, Robert, Watz, Henrik, Lutter, Johanna I, Lucke, Tanja, Biertz, Frank, Alter, Peter, Vogelmeier, Claus F, Kahnert, Kathrin

“…Adherence to COPD medication is often considered to be lower than in other chronic diseases. In view of the frequent comorbidities of COPD, the economic impact…”
Get full text

Folinic acid modulated bolus 5-FU or infusional 5-FU for adjuvant treatment of patients of UICC stage III colon cancer: Preliminary analysis of the PETACC-2-study by Carrato, A., Köhne, C., Bedenne, L., Popov, I., Bouche, O., Gaspar, E., Rougier, P., Schubert, U., Biertz, F., Becker, H.

“…Abstract only 3563 Background: Patients with stage III colon cancer have a high risk for recurrence. Infusional 5-FU may be more active than bolus application…”
Get full text